Eqis Capital Management, Inc. Adma Biologics, Inc. Transaction History
Eqis Capital Management, Inc.
- $1.14 Billion
- Q1 2025
A detailed history of Eqis Capital Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 15,279 shares of ADMA stock, worth $304,663. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,279Holding current value
$304,663% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
378Shares Held
188MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$372 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$336 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$257 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$228 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$113 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.92B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...